BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31175094)

  • 1. A Novel Oxoglutarate Dehydrogenase-Like Mediated miR-214/TWIST1 Negative Feedback Loop Inhibits Pancreatic Cancer Growth and Metastasis.
    Liu Y; Meng F; Wang J; Liu M; Yang G; Song R; Zheng T; Liang Y; Zhang S; Yin D; Wang J; Yang H; Pan S; Sun B; Han J; Sun J; Lan Y; Wang Y; Liu X; Zhu M; Cui Y; Zhang B; Wu D; Liang S; Liu Y; Song X; Lu Z; Yang J; Li M; Liu L
    Clin Cancer Res; 2019 Sep; 25(17):5407-5421. PubMed ID: 31175094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-1271 inhibits migration, invasion and epithelial-mesenchymal transition by targeting ZEB1 and TWIST1 in pancreatic cancer cells.
    Liu H; Wang H; Liu X; Yu T
    Biochem Biophys Res Commun; 2016 Apr; 472(2):346-52. PubMed ID: 26940738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-539 functions as a tumor suppressor in pancreatic cancer by targeting TWIST1.
    Yu H; Gao G; Cai J; Song H; Ma Z; Jin X; Ji W; Pan B
    Exp Mol Pathol; 2019 Jun; 108():143-149. PubMed ID: 31022384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling.
    Pan J; Fang S; Tian H; Zhou C; Zhao X; Tian H; He J; Shen W; Meng X; Jin X; Gong Z
    Mol Cancer; 2020 Jan; 19(1):9. PubMed ID: 31941509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Sox6 as a regulator of pancreatic cancer development.
    Jiang W; Yuan Q; Jiang Y; Huang L; Chen C; Hu G; Wan R; Wang X; Yang L
    J Cell Mol Med; 2018 Mar; 22(3):1864-1872. PubMed ID: 29369542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.
    Li LZ; Zhang CZ; Liu LL; Yi C; Lu SX; Zhou X; Zhang ZJ; Peng YH; Yang YZ; Yun JP
    Carcinogenesis; 2014 Feb; 35(2):469-78. PubMed ID: 24085799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia induces TWIST-activated epithelial-mesenchymal transition and proliferation of pancreatic cancer cells in vitro and in nude mice.
    Chen S; Chen JZ; Zhang JQ; Chen HX; Yan ML; Huang L; Tian YF; Chen YL; Wang YD
    Cancer Lett; 2016 Dec; 383(1):73-84. PubMed ID: 27693633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.
    Yoshino H; Yonemori M; Miyamoto K; Tatarano S; Kofuji S; Nohata N; Nakagawa M; Enokida H
    Oncotarget; 2017 Mar; 8(13):20881-20894. PubMed ID: 28152509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
    Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
    J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-15a-3p suppresses the growth and metastasis of ovarian cancer cell by targeting Twist1.
    Fan B; Chen LP; Yuan YH; Xiao HN; Lv XS; Xia ZY
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1934-1946. PubMed ID: 30915736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cordycepin (3'-deoxyadenosine) suppressed HMGA2, Twist1 and ZEB1-dependent melanoma invasion and metastasis by targeting miR-33b.
    Zhang P; Huang C; Fu C; Tian Y; Hu Y; Wang B; Strasner A; Song Y; Song E
    Oncotarget; 2015; 6(12):9834-53. PubMed ID: 25868853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
    Tao Y; Han T; Zhang T; Ma C; Sun C
    Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsa-microRNA-370-3p targeting Snail and Twist1 suppresses IL-8/STAT3-driven hepatocellular carcinoma metastasis.
    Peng S; Chen Y; Li T; Mao J; Yang P; Zou B; Luo L; Zhang W; Wang W; Xie R; Li J; Zeng L
    Cancer Sci; 2022 Dec; 113(12):4120-4134. PubMed ID: 36083239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Aurora-A-Twist1 axis promotes highly aggressive phenotypes in pancreatic carcinoma.
    Wang J; Nikhil K; Viccaro K; Chang L; Jacobsen M; Sandusky G; Shah K
    J Cell Sci; 2017 Mar; 130(6):1078-1093. PubMed ID: 28167680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TWIST1 upregulates miR-214 to promote epithelial-to-mesenchymal transition and metastasis in lung adenocarcinoma.
    Liu C; Luo J; Zhao YT; Wang ZY; Zhou J; Huang S; Huang JN; Long HX; Zhu B
    Int J Mol Med; 2018 Jul; 42(1):461-470. PubMed ID: 29693173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA ATB promotes the epithelial-mesenchymal transition by upregulating the miR-200c/Twist1 axe and predicts poor prognosis in breast cancer.
    Li RH; Chen M; Liu J; Shao CC; Guo CP; Wei XL; Li YC; Huang WH; Zhang GJ
    Cell Death Dis; 2018 Dec; 9(12):1171. PubMed ID: 30518916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway.
    Li ZX; Wu G; Jiang WJ; Li J; Wang YY; Ju XM; Yin YT
    Cell Cycle; 2020 Jan; 19(2):233-245. PubMed ID: 31876226
    [No Abstract]   [Full Text] [Related]  

  • 18. Nkx2.8 Inhibits Epithelial-Mesenchymal Transition in Bladder Urothelial Carcinoma via Transcriptional Repression of
    Yu C; Liu Z; Chen Q; Li Y; Jiang L; Zhang Z; Zhou F
    Cancer Res; 2018 Mar; 78(5):1241-1252. PubMed ID: 29311157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-200b/c-RAP1B axis represses tumorigenesis and malignant progression of papillary thyroid carcinoma through inhibiting the NF-κB/Twist1 pathway.
    Zhou B; Xu J; Chen Y; Gao S; Feng X; Lu X
    Exp Cell Res; 2020 Feb; 387(2):111785. PubMed ID: 31877303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer.
    Chen D; Dang BL; Huang JZ; Chen M; Wu D; Xu ML; Li R; Yan GR
    Oncotarget; 2015 Oct; 6(32):32701-12. PubMed ID: 26196741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.